Skip to main content

Gastrointestinal Neuroendocrine Tumors

  • Chapter
  • First Online:
Molecular Pathology of Endocrine Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 3))

  • 922 Accesses

Abstract

Gastrointestinal neuroendocrine tumors (GI-NETs) arise from diffuse neuroendocrine system cells, which express neuroendocrine markers, produce certain peptide or amine hormones, and contain dense core secretory granules. NETs still retain these features after the transformation of normal neuroendocrine cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dayal Y. The neuroendocrine cell system of the gut and pancreas: introduction and historical perspectives. In: Dayal Y, ed. CRC Press; 1991:1–32.

    Google Scholar 

  2. DeLellis RA: The neuroendocrine system and its tumors: an overview, Am J Clin Pathol. 2001; 115 suppl:S5-S16.

    Google Scholar 

  3. Soga J, Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer. 1971;28:990–998.

    Article  CAS  PubMed  Google Scholar 

  4. Smith DM Jr, Haggitt RC. A comparative study of generic stains for carcinoid secretory granules. Am J Surg Pathol. 1983;7:61–68.

    Article  PubMed  Google Scholar 

  5. Fahrenkamp AG, Wibbeke C, Winde G, et al. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract. Virchows Arch. 1995;426:361–367.

    Article  CAS  PubMed  Google Scholar 

  6. Taupenot L, Harper KL, O’Connor DT. The chromogranin-secretogranin family [see comment]. N Engl J Med. 2003;348:1134–1149.

    Article  CAS  PubMed  Google Scholar 

  7. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA. 1986;83:3500–3504.

    Article  CAS  PubMed  Google Scholar 

  8. Rode J, Dhillon AP, Doran JF, Jackson P, Thompson RJ. PGP 9.5, a new marker for human neuroendocrine tumours. Histo­pathology. 1985;9:147–158.

    Article  CAS  PubMed  Google Scholar 

  9. Schmechel D, Marangos PJ, Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 1978;276:834–836.

    Article  CAS  PubMed  Google Scholar 

  10. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1:238–239.

    Article  CAS  PubMed  Google Scholar 

  11. van Bogaert LJ. The diffuse endocrine system and derived tumours. Histological and histochemical characteristics. Acta Histochem. 1982;70:122–129.

    PubMed  Google Scholar 

  12. Jaffee IM, Rahmani M, Singhal MG, Younes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med. 2006;130:1522–1526.

    PubMed  Google Scholar 

  13. Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E. The “normal” endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci. 2004;1014:1–12.

    Article  CAS  PubMed  Google Scholar 

  14. DeLellis RA, Dayal Y, Wolfe HJ. Carcinoid tumors. Changing concepts and new perspectives. Am J Surg Pathol. 1984;8:295–300.

    Article  CAS  PubMed  Google Scholar 

  15. Solcia E, Kloppel G, Sobin LH. Endocrine tumors of the gastrointestinal tract. In: Solcia E, Kloppel G, Sobin LH, eds. New York: Springer-Verlag; 2000:61–68.

    Google Scholar 

  16. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13–27.

    Article  PubMed  Google Scholar 

  17. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.

    Article  CAS  PubMed  Google Scholar 

  18. Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757–762.

    Article  CAS  PubMed  Google Scholar 

  19. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959.

    Article  PubMed  Google Scholar 

  20. Rindi G, Villanacci V, Ubiali A. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors. Digestion. 2000;62(suppl 1):19–26.

    Article  CAS  PubMed  Google Scholar 

  21. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–407.

    Article  CAS  PubMed  Google Scholar 

  22. Bordi C, Corleto VD, Azzoni C, et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab. 2001;86:2236–2242.

    Article  CAS  PubMed  Google Scholar 

  23. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome [see comment]. N Engl J Med. 1990;322:723–727.

    Article  CAS  PubMed  Google Scholar 

  24. Klein A, Clemens J, Cameron J. Periampullary neoplasms in von Recklinghausen’s disease. Surgery. 1989;106:815–819.

    CAS  PubMed  Google Scholar 

  25. Kheir SM, Halpern NB. Paraganglioma of the duodenum in association with congenital neurofibromatosis. Possible relationship. Cancer. 1984;53:2491–2496.

    Article  CAS  PubMed  Google Scholar 

  26. Lollgen RM, Hessman O, Szabo E, Westin G, Akerstrom G. Chromosome 18 deletions are common events in classical midgut carcinoid tumors. Int J Cancer. 2001;92:812–815.

    Article  CAS  PubMed  Google Scholar 

  27. D’Adda T, Candidus S, Denk H, Bordi C, Hofler H. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions. J Pathol. 1999;189:394–401.

    Article  PubMed  Google Scholar 

  28. Higham AD, Bishop LA, Dimaline R, et al. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia [see comment]. Gastroenterology. 1999;116:1310–1318.

    Article  CAS  PubMed  Google Scholar 

  29. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–829.

    Article  CAS  PubMed  Google Scholar 

  30. Hoang MP, Hobbs CM, Sobin LH, Albores-Saavedra J. Carcinoid tumor of the esophagus: a clinicopathologic study of four cases. Am J Surg Pathol. 2002;26:517–522.

    Article  PubMed  Google Scholar 

  31. Ready AR, Soul JO, Newman J, Matthews HR. Malignant carcinoid tumour of the oesophagus [see comment]. Thorax. 1989;44:594–596.

    Article  CAS  PubMed  Google Scholar 

  32. Voillemot N, Potet F, Mary JY, Lewin MJ. Gastrin cell distribution in normal human stomachs and in patients with Zollinger-Ellison syndrome. Gastroenterology. 1978;75:61–65.

    CAS  PubMed  Google Scholar 

  33. Modlin IM, Nangia AK. The pathobiology of the human enterochromaffin-like cell. Yale J Biol Med. 1992;65:775-792. discussion 827–779.

    CAS  PubMed  Google Scholar 

  34. Freston JW, Borch K, Brand SJ, et al. Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis. Dig Dis Sci. 1995;40:50S-62S.

    Article  CAS  PubMed  Google Scholar 

  35. McCloy RF, Arnold R, Bardhan KD, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci. 1995;40:96S-120S.

    Article  CAS  PubMed  Google Scholar 

  36. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study [see comment]. Gastroenterology. 1993;104:994–1006.

    CAS  PubMed  Google Scholar 

  37. Solcia E, Rindi G, Fiocca R, et al. Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med. 1992;65:793-804. discussion 827–799.

    CAS  PubMed  Google Scholar 

  38. Richards AT, Hinder RA, Harrison AC. Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia - regression of tumors by antrectomy. A case report. S Afr Med J. 1987;72:51–53.

    CAS  PubMed  Google Scholar 

  39. Maury CP, Tornroth T, Teppo AM. Atrophic gastritis in Sjogren’s syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum. 1985;28:388–394.

    Article  CAS  PubMed  Google Scholar 

  40. D’Adda T, Keller G, Bordi C, Hofler H. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest. 1999;79:671–677.

    PubMed  Google Scholar 

  41. Azzoni C, Doglioni C, Viale G, et al. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol. 1996;20:433–441.

    Article  CAS  PubMed  Google Scholar 

  42. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J. Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol. 1990;14:503–513.

    Article  CAS  PubMed  Google Scholar 

  43. Bordi C, D’Adda T, Azzoni C, Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med. 1998;71:273–284.

    CAS  PubMed  Google Scholar 

  44. Cadiot G, Lehy T, Mignon M. Gastric endocrine cell proliferation and fundic argyrophil carcinoid tumors in patients with the Zollinger-Ellison syndrome. Acta Oncol. 1993;32:135–140.

    Article  CAS  PubMed  Google Scholar 

  45. Richards ML, Gauger P, Thompson NW, Giordano TJ. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg. 2004;28:652–658.

    Article  PubMed  Google Scholar 

  46. Borch K, Ahren B, Ahlman H, Falkmer S, Granerus G, Grimelius L. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242:64–73.

    Article  PubMed  Google Scholar 

  47. Rindi G, Solcia E. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol Clin North Am. 2007;36:851–865.

    Article  PubMed  Google Scholar 

  48. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988;41:185–200.

    Article  CAS  PubMed  Google Scholar 

  49. Solcia E, Fiocca R, Rindi G, Villani L, Cornaggia M, Capella C. The pathology of the gastrointestinal endocrine system. Endocrinol Metab Clin North Am. 1993;22:795–821.

    CAS  PubMed  Google Scholar 

  50. Solcia E, Fiocca R, Villani L, Luinetti O, Capella C. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol. 1995;19(suppl 1):S1-S7.

    PubMed  Google Scholar 

  51. Capella C SE, Sobin LH, Arnold R, Endocrine tumors of the small intestine. In: Hamilton SR AL, ed. Lyon: IARC Press; 2000:77–82.

    Google Scholar 

  52. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel G. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer. 1991;68:1329–1334.

    Article  CAS  PubMed  Google Scholar 

  53. Thom AK, Norton JA, Axiotis CA, Jensen RT. Location, incidence, and malignant potential of duodenal gastrinomas. Surgery. 1991;110:1086-1091. discussion 1091–1083.

    CAS  PubMed  Google Scholar 

  54. Merchant SH, VanderJagt T, Lathrop S, Amin MB. Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors. Am J Surg Pathol. 2006;30:1581–1587.

    Article  PubMed  Google Scholar 

  55. Dayal Y, Doos WG, O’Brien MJ, Nunnemacher G, DeLellis RA, Wolfe HJ. Psammomatous somatostatinomas of the duodenum. Am J Surg Pathol. 1983;7:653–665.

    Article  CAS  PubMed  Google Scholar 

  56. Dayal Y, Tallberg KA, Nunnemacher G, DeLellis RA, Wolfe HJ. Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. Am J Surg Pathol. 1986;10:348–357.

    Article  CAS  PubMed  Google Scholar 

  57. Fendrich V, Ramaswamy A, Slater EP, Bartsch DK. Duodenal somatostatinoma associated with Von Recklinghausen’s disease. J Hepatobiliary Pancreat Surg. 2004;11:417–421.

    Article  PubMed  Google Scholar 

  58. Karasawa Y, Sakaguchi M, Minami S, et al. Duodenal somatostatinoma and erythrocytosis in a patient with von Hippel-Lindau disease type 2A. Intern Med. 2001;40:38–43.

    Article  CAS  PubMed  Google Scholar 

  59. de Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Pract Res Clin Gastroenterol. 2005;19:705–715.

    Article  PubMed  Google Scholar 

  60. Bishop AE, Pietroletti R, Taat CW, Brummelkamp WH, Polak JM. Increased populations of endocrine cells in Crohn’s ileitis. Virchows Archiv A Pathol Anat Histopathol. 1987;410:391–396.

    Article  CAS  Google Scholar 

  61. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol. 1990;94:27–35.

    CAS  PubMed  Google Scholar 

  62. Anderson NH, Somerville JE, Johnston CF, Hayes DM, Buchanan KD, Sloan JM. Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study. Histopathology. 1991;18:61–65.

    Article  CAS  PubMed  Google Scholar 

  63. Stancu M, Wu T-T, Wallace C, Houlihan PS, Hamilton SR, Rashid A. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol. 2003;16:1189–1198.

    Article  PubMed  Google Scholar 

  64. Kuroda N, Mizushima S, Guo L, et al. Goblet cell carcinoid of the appendix: investigation of the expression of beta-catenin and E-cadherin. Pathol Int. 2001;51:283–287.

    Article  CAS  PubMed  Google Scholar 

  65. Lin BT, Gown AM. Mixed carcinoid and adenocarcinoma of the appendix: report of 4 cases with immunohistochemical studies and a review of the literature. Appl Immunohistochem Mol Morphol. 2004;12:271–276.

    PubMed  Google Scholar 

  66. Kortbeek J, Kelly JK, Preshaw RM. Carcinoid tumors and inflammatory bowel disease. J Surg Oncol. 1992;49:122–126.

    Article  CAS  PubMed  Google Scholar 

  67. Higaki S, Nishiaki M, Mitani N, Yanai H, Tada M, Okita K. Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy. 1997;29:171–175.

    Article  CAS  PubMed  Google Scholar 

  68. Oberg K. Interferons in the management of neuroendocrine tumors and their possible mechanism of action. Yale J Biol Med. 1992;65:519-529. discussion 531–516.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kuan, SF. (2010). Gastrointestinal Neuroendocrine Tumors. In: Hunt, J. (eds) Molecular Pathology of Endocrine Diseases. Molecular Pathology Library, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1707-2_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1707-2_24

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1706-5

  • Online ISBN: 978-1-4419-1707-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics